CSL (CSLLY) Inventory Turnover: 0.59 (As of Dec. 2025)

CSL CSLLY -2.30% 73 Inventory Turnover is 0.59 as of Dec. 2025. GuruFocus rates CSLLY with a GF Score™ of 73/100 and a GF Value™ of $50.49 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. CSL's Cost of Goods Sold for the six months ended in Dec. 2025 was $3,870 Mil. CSL's Average Total Inventories for the quarter that ended in Dec. 2025 was $6,518 Mil. CSL's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.59.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. CSL's Days Inventory for the six months ended in Dec. 2025 was 307.37.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CSL's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.81.

CSL (OTCPK:CSLLY) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

CSL's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	6518	/	3870	*	365 / 2
	=	307.37

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

CSL's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	6518	/	8092
	=	0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

CSL Inventory Turnover Related Terms

CSL Inventory Turnover Historical Data

* Premium members only.

The historical data trend for CSL's Inventory Turnover can be seen below:

CSL Inventory Turnover Chart

CSL Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Inventory Turnover

Get a 7-Day Free Trial

1.23

1.19

1.32

1.25

1.20

CSL Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.60	0.67	0.59	0.00	0.59

73GF Score

CSL Ltd CSLLY

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

CSL Inventory Turnover Calculation

CSL's Inventory Turnover for the fiscal year that ended in Jun. 2025 is calculated as

	Inventory Turnover (A: Jun. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Jun. 2025 )	/ (	(Total Inventories (A: Jun. 2024 )	+	Total Inventories (A: Jun. 2025 ))	/	count )
=	7479	/ (	(5964	+	6466)	/	2 )
=	7479	/	6215
=	1.20

CSL's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	3870	/ (	(6466	+	6570)	/	2 )
=	3870	/	6518
=	0.59

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.59 mean?

CSL (CSLLY) has a Inventory Turnover of 0.59 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on CSL and its competitors.

Is CSL's Inventory Turnover too high?

CSL's current Inventory Turnover is 0.59. Overall, CSL has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does CSL's Inventory Turnover compare to VRTX and REGN?

CSL's Inventory Turnover of 0.59 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on CSL and its competitors. CSL's current Inventory Turnover is 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is CSL stock overvalued right now?

Based on GuruFocus' analysis, CSL (CSLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $50.49, compared to a current price of $19.98 — trading 60.4% below its estimated fair value. The current Inventory Turnover is 0.59. CSL's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For CSL (CSLLY), the current Inventory Turnover is 0.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSL (CSLLY) Overvalued in 2026?

Based on GuruFocus' analysis, CSL stock appears to be undervalued. The current stock price of $19.98 is trading 60.4% below its estimated GF Value™ of $50.49. GuruFocus considers CSL to be Significantly Undervalued.

Key valuation signals for CSLLY:

Inventory Turnover: 0.59
GF Value™: $50.49 vs. price of $19.98 (60.4% below fair value)
GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the CSLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSL Business Description

Industry Healthcare Biotechnology

Comparable Companies ASX:TLX ASX:MSB ASX:NEU ASX:PYC ASX:CU6 ASX:RAC ASX:CUV ASX:TTX ASX:SPL ASX:OCC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ONC XKRX:068270 RPRX

Other Exchanges CMXHF:USA CSJ:Germany CSL:Australia

Address 655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website https://www.csl.com

CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

73GF Score

Get the complete analysis for CSLLY

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.98

Price

$50.49

GF Value

View CSLLY Analysis

See Inventory Turnover data for all stocks →